細胞凍結培地市場：タイプ、用途、最終用途別-2024-2030年の世界予測

細胞凍結培地市場規模は、2023年に1億8,571万米ドルと推定され、2024年には2億166万米ドルに達し、CAGR 8.71％で2030年には3億3,325万米ドルに達すると予測されています。

細胞凍結培地は、細胞を極低温で保存するための特殊なソリューションです。ジメチルスルホキシド（DMSO）やグリセロールなどの凍結保護剤をバランスよく混合したもので、凍結中の氷結晶形成から細胞を保護します。これらの凍結保護剤は、細胞の損傷を最小限に抑え、解凍時に細胞の生存率と機能性を維持する上で極めて重要です。先端バイオ医薬品に対する需要の急増と細胞治療分野の成長は、細胞凍結培地市場の好況にさらに貢献しています。これらの治療法は細胞の保存に大きく依存しており、効果的な凍結培地の役割は不可欠です。しかし、高度な保存技術には高いコストがかかり、細胞の取り扱いと保存に関する厳しい規制要件が、製造業者や供給業者に大きな課題を突きつけています。企業はコスト削減と規制遵守に努め、この環境下で機敏な対応を続けています。拡大機会は、カスタマイズされた凍結ソリューションの開発、新興国市場での成長、凍結保存の成果を向上させるためのAIやIoTなどの最先端技術の統合にあると見られています。

地域別インサイト

米国、カナダは、堅調なバイオテクノロジーセクター、充実した研究開発投資、大手製薬会社の存在により、細胞凍結培地市場の最前線に立っています。凍結保存技術や製剤に関する技術革新や特許が頻繁に報告されており、先進的な細胞凍結ソリューションに対する需要が高いことを示しています。細胞治療と再生医療の採用が、この地域の市場成長をさらに後押ししています。EMEAの細胞凍結培地市場は先進的であり、品質、革新性、厳格な規制基準の遵守を強く重視しています。この地域は幹細胞研究、個別化医療、バイオバンクに重点を置いており、洗練された細胞凍結ソリューションに対する安定した需要に貢献しています。研究協力やEUの資金提供によるイニシアチブは、市場力学において重要な役割を果たしています。中東・アフリカ地域は、研究活動への投資の増加とともに市場が緩やかに成長しており、細胞ベースの治療に対する意識の高まりが市場の進化に寄与しています。さらに、アジア太平洋地域は、バイオテクノロジーの著しい進歩や細胞長期保存のための凍結保存法への傾倒の高まりにより、細胞凍結培地市場の堅調な拡大を経験しています。研究開発活動、バイオバンクの増加、中国、日本、インドなどの国々における再生医療需要の急増がこの成長をさらに後押ししています。さらに、ヘルスケア・インフラの強化を目的とした政府の取り組みや、製薬・バイオ医薬品部門への投資の増加が、市場のプラス成長に寄与しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、細胞凍結培地市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を調査します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、細胞凍結培地市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、細胞凍結培地市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 先進的なバイオ医薬品に対する需要の急増とそれに伴うバイオバンキング活動の成長
    • 細胞培養ワクチンへの投資増加
    • バイオ医薬品製造における使い捨て技術の好感度の高まり
  • 抑制要因
    • 細胞生物学調査に伴う高コスト
  • 機会
    • 再生医療の進歩と高品質の凍結保存技術の必要性
    • 培地凍結保存におけるAIやIoTなどの先端技術の統合
  • 課題
    • 細胞凍結培地の承認と使用に関する厳格な規制要件
• 市場セグメンテーション分析
  • タイプ：複雑な皮膚疾患に対応するバイオ医薬品製剤におけるグリセロールベースの媒体の利用
  • 最終用途：製薬企業やバイオテクノロジー企業における新薬の発見と開発のための細胞凍結培地の使用が増加
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 細胞凍結培地市場：タイプ別

• ジメチルスルホキシドベースの培地
• グリセロールベースの培地
• 無血清培地

第7章 細胞凍結培地市場：用途別

• バイオバンキング
• がん調査
• 遺伝子工学とCRISPR技術
• 医薬品研究開発
• 再生医療
• ワクチン開発

第8章 細胞凍結培地市場：最終用途別

• 製薬・バイオテクノロジー企業
• 調査機関

第9章 南北アメリカの細胞凍結培地市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の細胞凍結培地市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの細胞凍結培地市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • サルトリウス、ポリプラスの買収を完了
  • QkineとSartoriusの提携により、高度な細胞モデルの分析のための完全なワークフローソリューションが実現
  • ExCell Bio、ウルグアイに新工場を開設
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CELL FREEZING MEDIA MARKET RESEARCH PROCESS
• FIGURE 2. CELL FREEZING MEDIA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CELL FREEZING MEDIA MARKET DYNAMICS
• FIGURE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL FREEZING MEDIA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY DIMETHYL SULFOXIDE-BASED MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY DIMETHYL SULFOXIDE-BASED MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GLYCEROL-BASED MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GLYCEROL-BASED MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY BIOBANKING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GENETIC ENGINEERING & CRISPR TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GENETIC ENGINEERING & CRISPR TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL RESEARCH & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL RESEARCH & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 37. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 38. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 39. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 40. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 41. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 42. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 43. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 44. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 45. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 48. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 49. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 50. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 51. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 52. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 53. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 54. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 55. CANADA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 56. CANADA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 57. CANADA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. CANADA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. CANADA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 60. CANADA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 61. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 62. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 63. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 64. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 65. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 66. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 69. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 72. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 73. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 74. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 77. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 80. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 82. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 83. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 84. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 85. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 88. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 89. CHINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 90. CHINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 91. CHINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 92. CHINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 93. CHINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 94. CHINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 95. INDIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. INDIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. INDIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. INDIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. INDIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 100. INDIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 101. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 104. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 105. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 106. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 107. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 110. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 111. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 112. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 113. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 114. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 115. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 118. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 119. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 120. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 121. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 122. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 123. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 124. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 125. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 126. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 127. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 130. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 131. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 132. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 133. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 134. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 135. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 136. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 137. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 142. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 143. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 144. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 145. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 146. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 147. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 148. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 149. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 154. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 157. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 158. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 159. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 160. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 161. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 162. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 163. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 164. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 165. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 166. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 167. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 168. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 169. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 174. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 175. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 178. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 179. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 180. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 181. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 186. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 187. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 188. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 189. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 190. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 191. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 192. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 193. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 196. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 197. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 198. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 199. ITALY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. ITALY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. ITALY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. ITALY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. ITALY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 204. ITALY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 205. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 206. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 207. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 208. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 209. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 210. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 211. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 212. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 213. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 214. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 215. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 216. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 217. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 220. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 221. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 222. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 223. POLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 224. POLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 225. POLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 226. POLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 227. POLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 228. POLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 229. QATAR CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 230. QATAR CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 231. QATAR CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. QATAR CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. QATAR CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 234. QATAR CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 235. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 236. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 237. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 238. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 239. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 240. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 241. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 242. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 243. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 246. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 247. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 250. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 251. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 252. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 253. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 254. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 255. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 256. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 257. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 258. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 259. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 264. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 265. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 266. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 267. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 268. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 269. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 270. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 271. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 274. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 275. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 276. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 277. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 278. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 279. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 280. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 281. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 282. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 283. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 284. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 285. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 286. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 287. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
• TABLE 288. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
• TABLE 289. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 290. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

[187 Pages Report] The Cell Freezing Media Market size was estimated at USD 185.71 million in 2023 and expected to reach USD 201.66 million in 2024, at a CAGR 8.71% to reach USD 333.25 million by 2030.

Cell freezing media is a specialized solution to preserve cells in extremely low temperatures. It comprises a balanced mixture of cryoprotectants, such as dimethyl sulfoxide (DMSO) and glycerol, protecting the cells from ice crystal formation during freezing. These cryoprotectants are crucial in minimizing cellular damage and maintaining cell viability and functionality upon thawing. The surging demand for advanced biopharmaceuticals and the growing cell therapy sector further contribute to the positive trajectory of the cell freezing media market. These therapies rely extensively on the preservation of cells, making the role of effective freezing media indispensable. However, the high cost of advanced preservation technologies and stringent regulatory requirements for cell handling and storage pose significant challenges for manufacturers and suppliers. Companies frequently work towards cutting costs and adhering to regulations to remain agile within the landscape. Expansion opportunities are seen in developing customized freezing solutions, growth in emerging markets, and integrating cutting-edge technologies such as AI and IoT to refine cryopreservation outcomes.

Regional Insights

In America, the United States, and Canada stand at the forefront of the cell-freezing media market, owing to its robust biotechnology sector, substantial research and development investments, and major pharmaceutical companies. Innovations and patents in cryopreservation techniques and formulations are frequently reported, demonstrating a high demand for advanced cell freezing solutions. Adopting cell therapy and regenerative medicine further propels market growth in the region. The EMEA market for cell freezing media is advanced, strongly emphasizing quality, innovation, and compliance with stringent regulatory standards. The region's focus on stem cell research, personalized medicine, and biobanking contribute to a steady demand for sophisticated cell freezing solutions. Research collaborations and EU-funded initiatives play a significant role in market dynamics. The Middle East and Africa region are experiencing gradual growth in the cell freezing media market with rising investment in research activities, and increasing awareness about cell-based therapies contributes to market evolution. Moreover, the Asia Pacific region is experiencing a robust expansion in the cell freezing media market, owing to significant advancements in biotechnology and an increasing inclination towards cryopreservation methods for long-term cell storage. A rise in research and development activities, biobanking, and a surge in demand for regenerative medicine across countries such as China, Japan, and India further fuels this growth. Additionally, government initiatives aimed at bolstering healthcare infrastructure, along with growing investments in the pharmaceutical and biopharmaceutical sectors, are contributing to the positive trajectory of the market.

Market Insights

• Market Dynamics

The market dynamics represent an ever-changing landscape of the Cell Freezing Media Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

• Market Drivers
  • The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
  • Increasing investment in cell culture-based vaccines
  • Growing preference for single-use technologies in biopharmaceutical production

• Market Restraints
  • High cost associated with cell biology research

• Market Opportunities
  • Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
  • Integration of advanced technologies such as AI and IoT in media cryopreservation

• Market Challenges
  • Strict regulatory requirements for the approval and use of cell freezing media
• Market Segmentation Analysis
  • Type: Utilization of Glycerol-based media in biopharmaceutical formulations to cater to sophisticated skin conditions
  • End-Use: Increasing usage of cell freezing media in pharmaceuticals and biotechnology firms for novel drug discovery and development

• Market Disruption Analysis
• Porter's Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cell Freezing Media Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cell Freezing Media Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Sartorius completes acquisition of Polyplus

Sartorius, an entity in the life sciences sector, completed the acquisition of Polyplus through its subsidiary, Sartorius Stedim Biotech. Polyplus specializes in developing and producing pivotal transfection reagents in viral vector manufacturing. This acquisition augments Sartorius's capabilities in this domain and signifies Polyplus's expansion into complementary technologies. By venturing into plasmid design and protein and plasmid production, Polyplus is diversifying its offerings and enhancing its technological portfolio to better serve the evolving needs of gene-modified cell and gene therapies. [Published On: 2023-07-18]

Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models

Qkine partnered with Sartorius to enrich stem cell and organoid research by integrating Qkine's expertise in creating bioactive growth factors and cytokines with Sartorius's advanced portfolio of cell analysis technologies. Sartorius, celebrated for accelerating life science research and pharmaceutical development, offers a broad spectrum of products, including reagents, assays, and pioneering technologies such as automated cell culture and live-cell imaging. This partnership is positioned to propel advancements in biologic discovery, streamline cell line development processes, and enhance the development of sophisticated cell models, thus delivering a holistic workflow solution to the scientific community. [Published On: 2023-07-06]

ExCell Bio Launches a New Factory in Uruguay

ExCell Biotechnology Co., Ltd. celebrated the opening of its new facility, ARTICA BIOTECH S.A. This significant milestone occurred within the Zonamerica Free Trade Zone on the northeastern outskirts of Montevideo, Uruguay. ExCell Bio has distinguished itself through its dedication to innovation in developing upstream tools for the biopharmaceutical industry. The inauguration of ARTICA BIOTECH S.A. marks the company's second establishment in Uruguay. ExCell Bio has achieved a significant position in China's market segment with its serum product line, underscoring its commitment to excellence and growing influence in the global marketplace. [Published On: 2023-05-04]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cell Freezing Media Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cell Freezing Media Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, AMSBIO, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Capricorn Scientific, Carl Roth GmbH + Co. KG, Celprogen Corporation, Charles River Laboratories, Elabscience Bionovation Inc., ExCell Biotechnology Co., Ltd, Funakoshi Co., Ltd., HiMedia Laboratories, Merck KGaA, NIPPON Genetics EUROPE GmbH, PAN-Biotech GmbH, PromoCell GmbH, Qiagen NV, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., and WELGENE Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Freezing Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Dimethyl Sulfoxide-based Media
  • Glycerol-Based Media
  • Serum-Free Media

• Application
  • Biobanking
  • Cancer Research
  • Genetic Engineering & CRISPR Technology
  • Pharmaceutical Research & Development
  • Regenerative Medicine
  • Vaccine Development

• End-Use
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
    • 5.1.1.2. Increasing investment in cell culture-based vaccines
    • 5.1.1.3. Growing preference for single-use technologies in biopharmaceutical production
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with cell biology research
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
    • 5.1.3.2. Integration of advanced technologies such as AI and IoT in media cryopreservation
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory requirements for the approval and use of cell freezing media
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Utilization of Glycerol-based media in biopharmaceutical formulations to cater to sophisticated skin conditions
  • 5.2.2. End-Use: Increasing usage of cell freezing media in pharmaceuticals and biotechnology firms for novel drug discovery and development
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cell Freezing Media Market, by Type

• 6.1. Introduction
• 6.2. Dimethyl Sulfoxide-based Media
• 6.3. Glycerol-Based Media
• 6.4. Serum-Free Media

7. Cell Freezing Media Market, by Application

• 7.1. Introduction
• 7.2. Biobanking
• 7.3. Cancer Research
• 7.4. Genetic Engineering & CRISPR Technology
• 7.5. Pharmaceutical Research & Development
• 7.6. Regenerative Medicine
• 7.7. Vaccine Development

8. Cell Freezing Media Market, by End-Use

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Research Institutes

9. Americas Cell Freezing Media Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cell Freezing Media Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cell Freezing Media Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Sartorius completes acquisition of Polyplus
  • 12.3.2. Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models
  • 12.3.3. ExCell Bio Launches a New Factory in Uruguay
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio